NEW ENGLAND JOURNAL OF MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-11-09 ms2000001241893328 来自山东省

偏重的研究方向：临床研究
经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2016-02-27 zhihenghuang

投了1篇病例报道，现在Assigned to an Editor，估计希望不大。

769 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-07-14 ms6000000447690824 来自广东省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：随机对照研究
经验分享：规范的多中心大样本的文章临床文章相对容易点被接收

167 0

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2022-04-27 大學朝陽

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：神经病学;神经介入
经验分享：Images in Clinical Medicine收录

1765 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-06-29 侠胆医心来自香港

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;综合医学;心血管
经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet

195 0

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-02-02 12588598m48暂无昵称来自福建省

偏重的研究方向：genetics;neurology
经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）

340 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2022-06-29 刘小川

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：寄生虫病
经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况

1591 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-05-03 病毒猎手来自美国

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：临床研究;临床医学;随机对照研究
经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。#NEJM##新英格兰医学杂志##期刊论坛#

245 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2020-07-08 765909885

各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。

1567 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1765, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145316, encodeId=3ebc2145316f4, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;综合医学;心血管 经验分享：影响因子158.5分，虽然比Lancet的168.9略低，但是原因在于NEJM上发表的新冠文章少，引用率略低一点。明年妥妥的超过Lancet, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:21:01 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2112695, encodeId=b787211269593, content=偏重的研究方向：genetics;neurology 经验分享：针对NEJM最近发的article写了一个letter过去，已经一个半月了还是letter submitted状态，没有变成with the editor不知道是什么情况，有哪位仁兄碰到过这种情况的吗T T （着急）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Thu Feb 02 09:25:09 CST 2023, time=2023-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229349, encodeId=ee8d122934966, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：寄生虫病 经验分享：2022年2月12日投稿，4月16日要求修改，5月5日返回，5月19日再次修改（仅询问是否能添加一句话），5月23日返回，至今一直是with the editor，也不知道什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1591, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e26f2130057, createdName=刘小川, createdTime=Wed Jun 29 08:04:10 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129787, encodeId=22112129e8779, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：临床研究;临床医学;随机对照研究 经验分享：国内2023年在NEJM上有可能突破8篇article!2025年十篇以上，以后每年10篇以上，到2030年每年可以达20篇！事实上NEJM每年article也仅100篇多一点。<a href='/topic/show?id=4041126241e' target=_blank style='color:#2F92EE;'>#NEJM#</a><a href='/topic/show?id=311b58614a5' target=_blank style='color:#2F92EE;'>#新英格兰医学杂志#</a><a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=12624, encryptionId=4041126241e, topicName=NEJM), TopicDto(id=58614, encryptionId=311b58614a5, topicName=新英格兰医学杂志), TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed May 03 02:33:50 CST 2023, time=2023-05-03, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=801732, encodeId=8817801e323c, content=各位大神，最近投了文章，先发了预审，编辑感兴趣，让投稿后，6月19号投稿的，大概10天左右到编辑手里的，补充了材料，现在Out for Review,请问大概多久能返回意见，被接收的概率高吗，有类似的情况吗？谢谢大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1567, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4064707085, createdName=765909885, createdTime=Wed Jul 08 15:10:57 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129515, encodeId=ce98212951592, content=学习<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=238, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Mon May 01 08:19:26 CST 2023, time=2023-05-01, status=1, ipAttribution=河北省)]

2023-05-01 ms2000000147841561 来自河北省

学习#CEL#

238 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务